Clinical Trial Update: Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant [Phase 2]

View source ↗

Summary

Clinical Trial Update for a phase 2 study of lenalidomide and dexamethasone with donor lymphocyte infusion in relapsed multiple myeloma after allogeneic stem ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Donor Lymphocyte Infusion
• Lenalidomide (lenalidomide)

Snippet

Sponsor: Ciusss de L'Est de l'Île de Montréal | Conditions: Relapsed Hematologic Malignancy, Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING